New dexamethasone combination yields two-fold improvement in median PFS in multiple myeloma

Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma

ASCO 2015: Latest developments in multiple myeloma

Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial

ASCO 2015: Latest in chronic lymphocytic leukaemia

Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma

Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL

Raloxifene retained approximately 81% of the effectiveness of tamoxifen in preventing invasive breast cancer

Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer

Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma

Letrozole vs observation for HR positive breast cancer

Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases